Understanding the Gut-Brain Connection

How the gut-brain connection works and why pharmacists should care

The gut-brain connection was covered in two CEimpact GameChangers Clinical Updates podcasts: Part 1 and Part 2. Lara Zakaria, PharmD, MS, CNS, CDN, IFMCP reminds us of a fundamental truth: the gut and brain are not isolated systems. Rather, they are in a constant two-way conversation, influencing everything from mood and motivation, to digestion and hormonal balance. The term often used to describe this is the gut-brain axis.

In these episodes, she unpacks key elements: the role of the gut microbiome, how common medications impact gut health (and ripple into mental health), and how pharmacists can counsel patients not just on GI symptoms but on mental wellness through the lens of gut health.

In this article, we’ll expand on that foundation with current scientific insights, practical take-aways for pharmacy practice, and evidence-based lifestyle interventions. The goal: help you (as a pharmacist or partner in care) recognize how small conversations about the gut can lead to big improvements in both gut and brain function.

Watch on YouTube:

What is the gut-brain axis?

The gut–brain axis refers to the bidirectional communication between the gastrointestinal (GI) tract (including its microbiome) and the central nervous system (CNS). Wikipedia+2SpringerLink+2

Key components of this communication include:

The enteric nervous system (“the gut’s brain”), which connects via nerves (e.g., the Vagus nerve) to the CNS. ScienceDirect+1
Microbial metabolites (short-chain fatty acids, bile acids, etc), neuroactive compounds produced or modulated by gut microbes. SpringerLink+1
Immune and endocrine signalling (gut barrier integrity, systemic inflammation, HPA-axis/hormone signalling). Cell+1
Dietary and medication influences on the gut microbiome and gut function, which feed back to brain function and mood.

In short: the gut sends signals to the brain, and vice-versa. Changes in one can ripple to the other.

Why is this important for mental health and mood?

In the podcast we learn about how gut health affects mood and motivation and the science backs this up.

Microbiome alterations & mood disorders: Recent systematic reviews show that gut microbiota variations are associated with anxiety and depression. For example, a 2025 review found that people with depression/anxiety often have different gut microbial signatures compared to controls. BioMed Central+2Nutritional Psychology+2
Mechanisms: How might this work? A few pathways:
Gut microbes produce or influence neurotransmitters (e.g., GABA, serotonin) and other neuroactive molecules. Wikipedia+1
Altered gut barrier / microbial dysbiosis can trigger immune-inflammation, which affects brain function. Cell+1
The stress-response system (HPA axis) is influenced by gut signals; chronic stress likewise alters gut microbiota. ScienceDirect+1
Clinical relevance: Although the evidence is still emerging, the implication is: improving gut health may support—not replace—traditional mental health care, but offers an adjunctive pathway. For example, diet modifications that enhance gut microbiome diversity may have positive mood/cognitive effects. SpringerLink+1

So for pharmacists: when a patient presents with GI symptoms + mood symptoms (e.g., anxiety, low mood) you have an opportunity to explore gut-brain links—and counsel accordingly.

What about medications and gut health?

This is a key practical area highlighted in the podcast: many medications impact gut function, microbiome, and thus may indirectly affect brain/mood. Some relevant points:

Antibiotics, proton-pump inhibitors (PPIs), some antidepressants/antipsychotics may alter gut microbiome composition (reduce diversity, create dysbiosis) which can influence gut-brain signalling. (While specific medication-to-microbiome research is still evolving, reviews emphasise that therapeutic drugs are part of the gut–brain conversation.) Journal of Pure and Applied Microbiology
GI dysfunction (e.g., irritable bowel syndrome, small intestinal bacterial overgrowth) may lead to increased gut permeability (aka “leaky gut”), allowing microbial-derived metabolites or immune mediators to reach systemic circulation and perhaps reach brain targets.
As a pharmacist, understanding which medications might “hit” the gut/microbiome (and thus potentially influence mood) means you can counsel patients: e.g., “This PPI may affect your gut microbiome; let’s watch for GI symptoms and also mood changes and try to mitigate via diet/lifestyle.”
Moreover, when you change a patient’s regimen (e.g., stop an antibiotic, start a long-term PPI) you might proactively discuss gut microbiome support.

So one actionable takeaway: Medication review → identify gut‐impacting meds → counsel on gut-brain risks & support strategies.

Actionable strategies for the pharmacist

Building on the science and the podcast discussion, here are practical strategies you can incorporate when counselling patients, especially those with co-occurring gut and mood/brain symptoms.

1. Tailored counseling tips

Normalize the gut-brain dialogue: Explain simply that “your gut and brain talk to each other—what happens in your gut can affect your mood, and what happens in your brain can affect digestion.” This frames GI + mood as linked, not separate.
Medication discussion: When dispensing or reviewing GI-active or CNS-active meds, mention potential microbiome/gut impact. For example: “Since this antibiotic may impact your gut bacteria, let’s also think about how your gut health might affect your mood or stress.”
Screen for dual symptoms: Ask patients with GI issues about mood/anxiety, and ask those with mood/anxiety about GI symptoms. If both are present, this may be an opportunity for gut-brain counselling.
Coordinate with other providers: If mood symptoms persist and GI symptoms are present, consider coordinating with dietitians/gastroenterologists/mental health professionals for integrative support.

2. Evidence-based lifestyle & nutrition guidance

Based on current research, you can counsel patients on lifestyle changes that support both gut and brain health.

High-fibre, plant-rich diet: Diets rich in diverse fibres support gut microbial diversity, increase beneficial metabolites (e.g., short-chain fatty acids) which favour healthy gut-brain signalling. Frontiers+1
Include fermented foods: Some evidence suggests fermented foods (yogurt, kefir, sauerkraut) may help microbial diversity and thus mood/cognitive outcomes (though evidence is emerging).
Avoid or limit ultra-processed foods: These often reduce microbial diversity and are linked to worse mood outcomes. SpringerLink
Stress management + sleep + exercise: These lifestyle factors also influence gut microbiota and gut-brain communication (via inflammation, HPA axis, microbial diversity). For example, chronic stress disrupts gut-brain axis signalling. ScienceDirect
Probiotics/prebiotics: While promising, the evidence is still mixed and not ready to replace core therapy. However, you can discuss as adjuncts: “Some probiotic strains may help mood/gut, but they’re not a substitute for your primary treatment.” Research reviews emphasise cautious optimism. BioMed Central+1

3. Integration into pharmacy practice

Use these talking points when patients pick up GI-active medications (e.g., PPIs, antibiotics, laxatives) or psychiatric medications: “Let’s also think about your gut, because it connects to your brain/mood.”
Provide handouts or quick guides: e.g., “Gut-Brain Healthy Diet Tips”, “What to ask if you’re on long-term PPI + mood changes”.
Monitor mood + GI symptoms together: When doing follow-up calls/consults, ask both: GI symptom status + mood/anxiety status. If changes in one, consider linking to the other.
Collaborate: Consider working with dietitians, psychologists, gastroenterologists to build referral pathways for patients whose gut-brain axis may be disrupted (e.g., IBS + anxiety).
Document intervention: When counselling on gut-brain axis, note medication risk, lifestyle recommendation, follow-up plan.

Case vignette (illustrative)

Scenario: A 45-year-old woman is on a 6-month course of a PPI for GERD. She reports lately she “just doesn’t feel herself,” feeling low-motivation, mild anxiety, and increased bloating and irregular bowel habits.

Pharmacist counselling approach:

Acknowledge the patient’s concerns: “I hear the GERD has required long-term PPI use, and you’re noticing both gut symptoms (bloating, irregular bowel) and mood changes.”
Briefly explain gut-brain axis: “We know your gut and brain are in constant conversation — so changes in gut function/microbiome (which can happen with long-term PPIs) may influence mood or stress responses.”
Review medication: Assess whether PPI is still needed or whether stepping down is possible (in liaison with prescriber). If continuing, acknowledge gut impact.
Introduce lifestyle support: “Let’s optimise your gut-brain health with some small changes:
Increase fibre from vegetables/legumes/whole grains (unless contraindicated)
Add fermented foods a few times per week
Manage stress (e.g., 10 min mindfulness) & ensure 7–8 h sleep
Monitor GI changes + mood together”
Set follow-up: “I’ll call you in 4-6 weeks to review how your GI symptoms + mood/anxiety are doing — and we’ll refine from there.”
Document counselling, ask patient to note both GI symptom diary + any mood/anxiety changes.

Rationale: By addressing both gut and brain in one conversation, you help the patient see their symptoms as connected rather than separate. The PPI’s impact on the gut/microbiome becomes part of the story rather than an isolated GI issue. And you provide actionable steps

Key take-aways

The gut-brain axis is real and meaningful: gut health (microbiome, digestion, inflammation) can influence brain/mood, and brain/mood/stress can influence gut.
As pharmacists, you’re in a prime position: many of your patients are on medications that affect the gut (and thus potentially the brain) and many have co-occurring GI + mood symptoms.
While not all evidence is settled, current research supports lifestyle and nutrition interventions (diet diversity, fibre, fermented foods, stress/sleep/exercise) as tools to support gut-brain health. Frontiers+1
Medication review is critical: identify gut­microbiome-impacting meds, monitor GI + mood symptoms together, counsel accordingly.
Small conversations (e.g., “Let’s talk about your gut and mood today”) can open the door to meaningful improvements in both. The podcast’s message is spot on: integrating gut-brain thinking into pharmacy practice can support patients managing both GI and mental health symptoms.

Final thoughts

The conversation between gut and brain is continuous and for patients, it often happens behind the scenes. As a pharmacist, your role is to bring that dialogue into the open: to help patients understand “what’s going on between my gut and my mood” and to structure practical, evidence-informed steps to strengthen that connection in the right direction.

The path isn’t about replacing standard mental-health treatment or GI treatment — it’s about adding a dimension: gut-brain wellness. By doing so, you help patients see their care more holistically, encourage lifestyle choices that support both organ systems, and foster better monitoring and collaboration.

Tune into the podcast, embrace the gut-brain axis lens in your consultations, and you might find that the small talk about gut symptoms becomes a big contributor to better mood, cognition and quality of life.